Labshake search

8651 - 8700 of 10000+ citations for Anti CD337 Antibody since 2019

• Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-I

  Young Rock Chung, et al., bioRxiv - Immunology 2023

  Quote: ... anti-mouse CD11c (clone: N418, PerCP Cy5.5, Biolegend, cat# 117328 ...
• Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-I

  Young Rock Chung, et al., bioRxiv - Immunology 2023

  Quote: ... anti-mouse CD45.1 (clone: A20, PE-Cy7, Biolegend, cat# 110730 ...
• Innate extracellular Hsp70 inflammatory properties are mediated by the interaction of Siglec-E and LOX-1 receptors

  Thiago J. Borges, et al., bioRxiv - Immunology 2023

  Quote: ... and mouse anti-c-Myc (clone 9E10, Biolegend) were used as 1:300 ...
• PD-1 Mediated Regulation of Unique Activated CD8⁺ T Cells by NK Cells in the Submandibular Gland

  Samantha M. Borys, et al., bioRxiv - Immunology 2023

  Quote: ... anti-CD3e-PE (Biolegend 100308, clone 145-2C11), and different TotalSeq-C Anti-Mouse Hashtags (TotalSeq-C Anti-Mouse Hashtags 1-10 Biolegend #155861-155879 (Supplemental Tables 1 and 2) ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD27-APC (clone M-T271, BioLegend), anti-human CD27-APC/Cy7 (clone O323 ...
• FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 Breast

  Curtis W. McCloskey, et al., bioRxiv - Cell Biology 2023

  Quote: ... and anti-CD49f-FITC (BioLegend, 313606, 1:100). Live cells were selected based on Dapi (Sigma ...
• FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 Breast

  Curtis W. McCloskey, et al., bioRxiv - Cell Biology 2023

  Quote: ... anti-CD31-PE/Cy7 (BioLegend, 303118, 1:50), and for mammary epithelial cells subsets ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD123-PE (1:40, Biolegend, clone 6H6), anti-CD49f-PE/Dazzle594 (1:160 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD117-BV785 (1:40, Biolegend, clone 104D2), anti-CD45RA-BB515 (1:40 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD34-APC (1:160, Biolegend, clone 581), anti-CD2-PE/Cy5 (1:160 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD10-BV605 (1:40, Biolegend, clone HI10a), anti-CD117-BV785 (1:40 ...
• A deep lung cell atlas reveals cytokine-mediated lineage switching of a rare cell progenitor of the human airway epithelium

  Avinash Waghray, et al., bioRxiv - Cell Biology 2023

  Quote: ... and anti-human CD56–BV711 (1:100; BioLegend) for 20 minutes at room temperature ...
• A deep lung cell atlas reveals cytokine-mediated lineage switching of a rare cell progenitor of the human airway epithelium

  Avinash Waghray, et al., bioRxiv - Cell Biology 2023

  Quote: ... or anti-human CD45–BV421 (1:100; BioLegend), anti-human CD31–BV421 (1:100 ...
• Mutation-specific CAR T cells as precision therapy for IGLV3-21^R110 expressing high-risk chronic lymphocytic leukemia

  Florian Märkl, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-mouse CD45 (30F11, Biolegend, San Diego, USA), anti-human CD19 (HIB19 ...
• Mutation-specific CAR T cells as precision therapy for IGLV3-21^R110 expressing high-risk chronic lymphocytic leukemia

  Florian Märkl, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-human CD3 (UCHT1, Biolegend, San Diego, USA), anti-human CD14 (TuK4 ...
• Mutation-specific CAR T cells as precision therapy for IGLV3-21^R110 expressing high-risk chronic lymphocytic leukemia

  Florian Märkl, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-human CD19 (HIB19, Biolegend, San Diego, USA), anti-human CD3 (UCHT1 ...
• The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions

  Mark S. Lee, et al., bioRxiv - Immunology 2023

  Quote: ... and anti- pPLCγ1 (clone A17025A, PE conjugate, BioLegend) in a separate sample tube at the vendor-recommended concentrations ...
• The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions

  Mark S. Lee, et al., bioRxiv - Immunology 2023

  Quote: ... Anti-mouse IL-2 (clone JES6-1A12, BioLegend) antibody was used to capture IL-2 from the supernatants ...
• Immunoproximity biotinylation reveals the axon initial segment proteome

  Wei Zhang, et al., bioRxiv - Neuroscience 2023

  Quote: ... mouse anti-Neurofilament (Biolegend, Cat# 837904, 1:1000), mouse anti-MAP2 (Sigma-Aldrich ...
• T cell migration requires ion and water influx to regulate actin polymerization

  Leonard L. de Boer, et al., bioRxiv - Immunology 2023

  Quote: ... biotin-conjugated anti-CD44 (IM7 rat monoclonal, BioLegend) and one of these primary antibodies ...
• Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma

  Johanna Chiffelle, et al., bioRxiv - Cancer Biology 2023

  Quote: ... cells were directly stained with anti-CD45 (BioLegend) and viability stained with PI and Hoechst ...
• Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain

  Qingqing Feng, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-mouse CD8a PE/Cyanine7 (Biolegend, Cat: #100722), anti-mouse/human B220 APC/Cyanine7 (Biolegend ...
• Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain

  Qingqing Feng, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-mouse CD62L PE/Cyanine7 (Biolegend, Cat: #104418), anti-mouse CD8a PE/Cyanine7 (Biolegend ...
• Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain

  Qingqing Feng, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-mouse CD86 PE/Cyanine7 (Biolegend, Cat: #105014), anti-mouse IFNγ PE/Cyanine7 (Biolegend ...
• Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain

  Qingqing Feng, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-mouse EpCAM PE/Cyanine7 (Biolegend, Cat: #118215), anti-mouse CD38 PE/Cyanine7 (Biolegend ...
• Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain

  Qingqing Feng, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-mouse CD38 PE/Cyanine7 (Biolegend, Cat: #102718), anti-mouse IL2 PE/Cyanine7 (Biolegend ...
• Single-cell transcriptomics reveals heterogenous thymic dendritic cell subsets with distinct functions and requirements for thymocyte-regulated crosstalk

  Jayashree Srinivasan, et al., bioRxiv - Immunology 2023

  Quote: ... for aDC1s or anti-CD11c-biotin (N418, Biolegend), anti-SIRPα (P84 ...
• PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis

  Athina Boumpas, et al., bioRxiv - Immunology 2023

  Quote: ... anti-CD34-Brilliant Violet 421 (BioLegend, MEC14.7, #119321), anti-CD135-Brilliant Violet 421 (BioLegend ...
• PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis

  Athina Boumpas, et al., bioRxiv - Immunology 2023

  Quote: ... anti-Ly-6C-PerCP (BioLegend, clone HK1.4, # 128028), anti-CD274 (B7-H1 ...
• PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis

  Athina Boumpas, et al., bioRxiv - Immunology 2023

  Quote: ... anti-Ly-6G-PE (BioLegend, clone 1A8, #127608), anti-Ly-6G-PE/Cyanine7 (BioLegend ...
• PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis

  Athina Boumpas, et al., bioRxiv - Immunology 2023

  Quote: ... anti-CD16/32-FITC (BioLegend, clone 93, #101306), anti-CD16/32-PE/Cyanine7( BioLegend ...
• PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis

  Athina Boumpas, et al., bioRxiv - Immunology 2023

  Quote: ... anti-CD11b-FITC (BioLegend, clone M1/70, #101206), anti-Gr-1-PE (BioLegend ...
• PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis

  Athina Boumpas, et al., bioRxiv - Immunology 2023

  Quote: ... anti-Ly-6C-BrilliantViolet421 (BioLegend, clone HK1.4, #128032), anti-Ly-6C-PerCP (BioLegend ...
• Rapid activation of IL-2 receptor signaling by CD301b⁺ DC-derived IL-2 dictates the outcome of helper T cell differentiation

  Naoya Tatsumi, et al., bioRxiv - Immunology 2023

  Quote: ... After blocking with anti-CD16/CD32 (2.4G2, BioLegend), cells were stained for cell surface molecules on ice for 20 min ...
• Lag3 and PD-L1 govern T cell receptor signal duration in adaptively tolerised CD4⁺ T cells

  Lozan Sheriff, et al., bioRxiv - Immunology 2024

  Quote: ... in vivo grade anti-Lag3 (clone C9B7W BioLegend) or rat IgG1 (clone MAC221) ...
• Divergent cytokine and transcriptional signatures control functional T follicular helper cell heterogeneity

  Lennard Dalit, et al., bioRxiv - Immunology 2024

  Quote: ... anti-CXCR3 (1:200; clone CXCR3-173; BioLegend) and anti-CCR6 (1:200 ...
• Divergent cytokine and transcriptional signatures control functional T follicular helper cell heterogeneity

  Lennard Dalit, et al., bioRxiv - Immunology 2024

  Quote: ... and anti-CD45RO (1:20; clone UCHL1; BioLegend).
• Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization

  Lauren B. Banks, et al., bioRxiv - Immunology 2024

  Quote: ... 20μg/ml anti-IL12/23p40 (Biolegend, cat # 505303) 7.5ng/ml recombinant IL-4 (Peprotech ...
• Human placental organoids as a model to probe early gestation maternal immune dynamics

  Emily M. Slaby, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-CD8 BV650 (BioLegend catalog #344730, clone SK1), anti-CD40L (CD154 ...
• Human placental organoids as a model to probe early gestation maternal immune dynamics

  Emily M. Slaby, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-CD38 PE (BioLegend catalog #303506, clone HIT2), anti-FOXP3 PE/Dazzle 594 (BioLegend catalog #320126 ...
• Human placental organoids as a model to probe early gestation maternal immune dynamics

  Emily M. Slaby, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-CD16 BV785 (BioLegend catalog #302046, clone 3G8), anti-CD158a (KIR2DL1 ...
• Human myogenic progenitor cells display tenogenic differentiation potential and facilitate tendon regeneration

  Xiexiang Shao, et al., bioRxiv - Cell Biology 2024

  Quote: ... and PE anti-human CD56 (BioLegend, cat#304606) for 45 min at 4°C ...
• Cell of origin alters myeloid-mediated immunosuppression in lung adenocarcinoma

  Minxiao Yang, et al., bioRxiv - Cancer Biology 2024

  Quote: ... anti-mouse Ly6g-FITC (1:300, 127605, Biolegend), anti-mouse/human CD11b-PE/Dazzle 594 (1:120 ...
• Pharmacological control of CAR T cells through CRISPR-driven rapamycin resistance

  Sébastien Levesque, et al., bioRxiv - Cancer Biology 2024

  Quote: ... mouse anti-human CD4 AF700 (BioLegend Cat 300526), mouse anti-human CD8 PerCP (BioLegend Cat 301030) ...
• Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer

  Marc J. Williams, et al., bioRxiv - Cancer Biology 2024

  Quote: ... FITC-conjugated anti-CD31 (1:100, Biolegend 303103) and Alexa Fluor 488 anti-CD45 (1:100 ...
• Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer

  Marc J. Williams, et al., bioRxiv - Cancer Biology 2024

  Quote: ... PE-conjugated anti-CD49f (1:100, Biolegend 313612), FITC-conjugated anti-CD31 (1:100 ...
• Pharmacological control of CAR T cells through CRISPR-driven rapamycin resistance

  Sébastien Levesque, et al., bioRxiv - Cancer Biology 2024

  Quote: ... mouse anti-human CD279 BV421 (BioLegend Cat 329920), mouse anti-human CCR7 APC-Fire 750 (BioLegend Cat 353246) ...
• Pharmacological control of CAR T cells through CRISPR-driven rapamycin resistance

  Sébastien Levesque, et al., bioRxiv - Cancer Biology 2024

  Quote: ... mouse anti-human CD8 PerCP (BioLegend Cat 301030), mouse anti-human CD279 BV421 (BioLegend Cat 329920) ...
• Coordinated differentiation of human intestinal organoids with functional enteric neurons and vasculature

  Charlie J. Childs, et al., bioRxiv - Bioengineering 2024

  Quote: ... mouse anti-TUBB3 1:200 (BioLegend Cat# 801201), sheep anti-SM22 1:500 (Novus Cat# AF7886) ...
• Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia

  Ling Zhou, et al., bioRxiv - Pharmacology and Toxicology 2024

  Quote: ... and anti-CD62P (BioLegend, San Diego, CA, USA). The antibodies were incubated in the dark for 30 min on ice.